Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012
Crossref DOI link: https://doi.org/10.1186/s13023-017-0578-4
Published Online: 2017-02-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pauwels, Kim
Huys, Isabelle
Casteels, Minne
Larsson, Kristina
Voltz, Caroline
Penttila, Karri
Morel, Thomas
Simoens, Steven
Funding for this research was provided by:
Agentschap voor Innovatie door Wetenschap en Technologie
Fonds Wetenschappelijk Onderzoek